Biology of Reproduction, Vol 29, 680-688, Copyright © 1983 by Society for the Study of Reproduction

ARTICLES

Uterine and placental prostaglandins and their modulation of oxytocin sensitivity and contractility in the parturient uterus

WY Chan

The parturient uterus develops a markedly enhanced sensitivity to the uterotonic action of oxytocin (OT). The mechanism leading to this enhanced OT sensitivity is not known. Our previous work suggested that prostaglandins (PGs) may be involved. To define the relationship between OT sensitivity and uterine PG production, we measured uterine sensitivity to OT by a quantitative dose-response procedure in rats on Days 19, 20, 21 and 22 of pregnancy and monitored uterine and placental tissue concentrations of PGF2 alpha and PGE2. In addition, we determined the effects of inhibition of endogenous PG synthesis on OT sensitivity and uterine contractility. We found that both OT sensitivity and spontaneous contractility are positively related to uterine PGF2 alpha production. An abrupt increase in OT sensitivity was observed on Days 21 and 22 of pregnancy. The increase in OT sensitivity was coincidental with the marked increase in PGF2 alpha production in the uterus on Days 21 and 22 of pregnancy. Suppression of in vivo PG synthesis caused a reduction in both spontaneous uterine contractility and OT-induced contractions. Uterine PGE2 concentrations and release were 3-5 times lower than PGF2 alpha. There were no significant fluctuations of uterine PGE2 concentration measured on these last 4 days of gestation. Placental PG levels were also found not to be related to uterine contractility. Placental PGE2 levels were higher than PGF2 alpha and may play a regulatory role in placental perfusion. However, placental PGs did not vary with gestational age.

This article has been cited by other articles:

				D. M. Olson The Promise of Prostaglandins: Have They Fulfilled Their Potential as Therapeutic Targets for the Delay of Preterm Birth? Reproductive Sciences, October 1, 2005; 12(7): 466 - 478. [Abstract] [PDF]

				H. Y. Al-Matubsi, A. L.W. Eis, J. Brodt-Eppley, D. J. MacPhee, S. Lye, and L. Myatt Expression and Localization of the Contractile Prostaglandin F Receptor in Pregnant Rat Myometrium in Late Gestation, Labor, and Postpartum Biol Reprod, October 1, 2001; 65(4): 1029 - 1037. [Abstract] [Full Text] [PDF]

				E. Karteris, D. Grammatopoulos, H. Randeva, and E. W. Hillhouse Signal Transduction Characteristics of the Corticotropin-Releasing Hormone Receptors in the Feto-Placental Unit J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1989 - 1996. [Abstract] [Full Text]

				Y.-L. Dong and C. Yallampalli Pregnancy and Exogenous Steroid Treatments Modulate the Expression of Relaxant EP2 and Contractile FP Receptors in the Rat Uterus Biol Reprod, March 1, 2000; 62(3): 533 - 539. [Abstract] [Full Text]

				J. Brodt-Eppley and L. Myatt Changes in Expression of Contractile FP and Relaxatory EP2 Receptors in Pregnant Rat Myometrium during Late Gestation, at Labor, and Postpartum Biol Reprod, October 1, 1998; 59(4): 878 - 883. [Abstract] [Full Text]